TY - JOUR
KW - Buprenorphine/therapeutic use
KW - COVID-19
KW - Humans
KW - Male
KW - Middle Aged
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Pandemics
KW - Retrospective Studies
KW - SARS-CoV-2
KW - Treatment Outcome
KW - buprenorphine
KW - COVID-19 Pandemic
KW - Cascade of care
KW - opioid use disorder
AU - C. O. Cunningham
AU - L. Khalid
AU - Y. Deng
AU - K. Torres-Lockhart
AU - M. Masyukova
AU - S. Thomas
AU - C. Zhang
AU - T. Lu
A1 - 
AD - Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, United States of America. Electronic address: chinazo.cunningham@einsteinmed.org.; Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, United States of America.; Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, United States of America.; Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, United States of America.; Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, United States of America.; Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, United States of America.; Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, United States of America.; Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, NY, United States of America.
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
DO - 10.1016/j.jsat.2021.108641
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PY - 2022
SN - 1873-6483; 0740-5472; 0740-5472
SP - 108641
T1 - A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic
T2 - Journal of substance abuse treatment
TI - A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 34863608
U3 - 10.1016/j.jsat.2021.108641
VL - 135
VO - 1873-6483; 0740-5472; 0740-5472
Y1 - 2022
Y2 - Apr
ER -